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Lamins are intermediate filament proteins that assemble into a meshwork underneath the inner nuclear mem-
brane, the nuclear lamina. Mutations in the LMNA gene, encoding lamins A and C, cause a variety of diseases
collectively called laminopathies. The disease mechanism for these diverse conditions is not well understood.
Since lamins A and C are fundamental determinants of nuclear structure and stability, we tested whether
defects in nuclear mechanics could contribute to the disease development, especially in laminopathies affect-
ing mechanically stressed tissue such as muscle. Using skin fibroblasts from laminopathy patients and lamin
A/C-deficient mouse embryonic fibroblasts stably expressing a broad panel of laminopathic lamin A mutations,
we found that several mutations associated with muscular dystrophy and dilated cardiomyopathy resulted in
more deformable nuclei; in contrast, lamin mutants responsible for diseases without muscular phenotypes
did not alter nuclear deformability. We confirmed our results in intact muscle tissue, demonstrating that
nuclei of transgenic Drosophila melanogaster muscle expressing myopathic lamin mutations deformed more
under applied strain than controls. In vivo and in vitro studies indicated that the loss of nuclear stiffness
resulted from impaired assembly of mutant lamins into the nuclear lamina. Although only a subset of lamin
mutations associated with muscular diseases caused increased nuclear deformability, almost all mutations
tested had defects in force transmission between the nucleus and cytoskeleton. In conclusion, our results
indicate that although defective nuclear stability may play a role in the development of muscle diseases,
other factors, such as impaired nucleo-cytoskeletal coupling, likely contribute to the muscle phenotype.
INTRODUCTION
The mammalian nucleus is the largest organelle within the
cell. It is separated from the cytoplasm by the nuclear enve-
lope. The nuclear envelope consists of the outer nuclear mem-
brane, which is continuous with the rough endoplasmic
reticulum, the inner nuclear membrane and the nuclear
lamina (1). The lamina is a proteinaceous network located
underneath the inner nuclear membrane and is tightly con-
nected to nuclear pore complexes and nuclear envelope trans-
membrane proteins. The lamina is primarily formed by two
distinct types of proteins, referred to as A- and B-type
∗To whom correspondence should be addressed at: Weill Hall, Room 235, Cornell University, Ithaca, NY 14853, USA. Tel: +1 607 2551700;
Fax: +1 607 2555961; Email: jan.lammerding@cornell.edu
# The Author 2013. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Molecular Genetics, 2013, Vol. 22, No. 12 2335–2349
doi:10.1093/hmg/ddt079
Advance Access published on February 19, 2013
lamins (2). Lamins are type-V intermediate filaments (3,4), i.e.
fibrous proteins with a characteristic tripartite structural organ-
ization: an extended, central a-helical ‘rod’ domain flanked by
non-a-helical N- and C-terminal domains. Lamins form
coiled-coil dimers through interactions of the central rod
heptad sequence repeats and further assemble into higher
order structures (5,6). In mammalian somatic cells, the most
abundant isoforms are lamins A and C, which arise from a
single gene, LMNA, by alternative splicing (7), and lamin
B1 and B2, encoded by the genes LMNB1 and LMNB2, re-
spectively (8,9). Lamins A/C form interactions with a multi-
tude of nuclear components and are involved in many major
nuclear processes, including DNA replication and repair, chro-
matin organization, transcriptional regulation and stem-cell
maintenance and differentiation (reviewed in 10). The recent
discovery that mutations in the LMNA gene cause a large
variety of human diseases, collectively termed laminopathies,
resulted in a rapidly growing interest in the biological func-
tions of lamins A and C. Laminopathies include the autosomal
dominant form of Emery–Dreifuss muscular dystrophy
(EDMD), limb–girdle muscular dystrophy, dilated cardiomy-
opathy (DCM), familial partial lipodystrophy (FPLD) and the
segmental aging disease Hutchison–Gilford progeria syn-
drome (11–13). Despite much progress, it remains unclear
how mutations in a single, nearly ubiquitously expressed
gene can cause such a variety of disorders and why the major-
ity of the more than 400 mutations identified to date primarily
affect muscle tissue, whereas other laminopathies mostly
lack muscular phenotypes (11,13). Intriguingly, lamin muta-
tions resulting in the same disease are often scattered across
the length of the gene, whereas in other cases, different
mutations in the same amino acid can cause distinct disease
phenotypes (13).
Different, non-mutually exclusive hypotheses have been
proposed to explain the broad range of laminopathies: the
‘structural hypothesis’ postulates that mutated lamins assem-
ble into a structurally impaired lamina and lead to more
fragile nuclei that rupture and result in cell death, especially
in mechanically stressed tissue such as muscle. A variation
of the ‘structural hypothesis’ is that mutations in lamins do
not affect nuclear stability directly, but rather affect lamin
interactions with components of the linker of nucleoskeleton
and cytoskeleton (LINC) complex (14), which provides a
physical connection between the nuclear interior and the cyto-
skeleton (15,16). Decreased LINC complex formation might
result in impaired nucleo-cytoskeletal coupling, and thereby
cause disease. The ‘gene expression hypothesis’ proposes
that mutations in lamins A/C can alter gene regulation, and
that misregulated, tissue-specific signaling pathways give
rise to the various disease phenotypes (17–20). Other hypoth-
eses include altered stem-cell conservation and differentiation,
which could result in impaired tissue maintenance and regen-
eration in laminopathies (21).
Previous studies have identified lamins A and C as funda-
mental determinants of nuclear mechanical properties and
demonstrated that loss of lamin A/C causes weaker, more de-
formable nuclei (19,22,23). However, the effect of specific
disease-causing lamin mutations on nuclear mechanics has
never been systematically tested. Therefore, it remains
unclear whether mutations responsible for muscular pheno-
types have more severe effects on nuclear mechanics com-
pared with mutations linked to other laminopathies. In this
study, we systematically tested the effect of laminopathic
mutations on various aspects of nuclear mechanics, including
nuclear stiffness (i.e. the extent to which the nucleus resists
deformation) and nuclear fragility, both aspects of the stability
of a nucleus under mechanical stress, as well as nucleo-
cytoskeletal coupling, which describes the ability to transmit
intracellular forces between the cytoskeleton and nuclear inter-
ior. We evaluated nuclear stiffness in skin fibroblasts from
patients with EDMD and FPLD, in a panel of Lmna+/2
mouse embryonic fibroblasts (MEFs) genetically modified to
stably express physiological levels of mutant or wild-type
lamin A, and in intact Drosophila melanogaster larval body
wall muscle tissue expressing various EDMD mutations. We
complemented these studies with assays to evaluate the
effect of specific mutations on lamin assembly in vivo and
in vitro and on force transmission between the nucleus and
cytoskeleton. Our results suggest that specific myopathic
lamin A mutations interfere with normal lamin assembly and
result in a loss of nuclear stability that likely contributes to
muscle-specific phenotypes, but that also other factors, such
as impaired nucleo-cytoskeletal coupling, play a role in the
development of muscular laminopathies.
RESULTS
Fibroblasts from EDMD patients show increased nuclear
deformability
Cells and biopsies from laminopathy patients and mouse
models often display misshapen or ruptured nuclei (24–29),
providing anecdotal support for the hypothesis that mutated
lamins may alter the lamina structure in a way that renders
nuclei more susceptible to mechanical stress (30,31). To test
whether lamin A/C mutations linked to muscular diseases
(e.g. EDMD, DCM) cause particularly strong defects in
nuclear mechanics and thereby promote muscular phenotypes,
we assessed the mechanical properties of nuclei in primary
skin fibroblasts from EDMD patients and compared them
with cells from FPLD patients and healthy controls. Nuclear
stiffness of adherent cells was inferred from the induced
nuclear deformations in response to substrate strain applica-
tion (32). We found that nuclei of cells from two EDMD
patients, carrying the LMNA mutations DK32 and E358K,
respectively, deformed significantly more than those from
passage-matched healthy controls (Fig. 1A), indicating
increased nuclear deformability in the EDMD cells. In con-
trast, cells from two FPLD patients with the LMNA mutations
R482Q and R482L, respectively, had normal nuclear stiffness.
In addition, we observed that cells from EDMD patients
became more frequently damaged during the strain application
than cells from healthy controls, indicating increased sensitiv-
ity to mechanical stress (Supplementary Material, Fig. S1A
and B). In particular, close to 12% of EDMD fibroblasts
with the LMNA E358K mutation were damaged during strain
application, whereas ,1% of cells were damaged in the
three control cell lines (Supplementary Material, Fig. S1C).
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Lamin mutations causing EDMD or DCM, but not FPLD,
fail to restore nuclear stiffness
Since analysis of patient fibroblasts is limited by the heteroge-
neous genetic background and the limited availability of
samples, we developed a comprehensive approach to test a
wider panel of lamin A mutations associated with EDMD,
DCM and FPLD in a genetically uniform background.We ecto-
pically expressed mutant or wild-type lamin A in MEFs lacking
a single Lmna allele (Lmna+/2 MEFs), which express only
50% of the normal levels of lamin A/C (33,34). The lamin
mutationswere introducedwith a bicistronic retroviral construct
consisting of non-tagged human lamin A and a ZsGreen fluores-
cent reporter. Since both proteins are translated from a single
bicistronic mRNA transcript and expressed at similar levels,
we were able to sort for cells with physiological levels of ecto-
pically expressed lamin A by fluorescence-activated cell sorting
for ZsGreen. The resulting model system closely resembles the
situation in laminopathy patients, who typically carry autosomal
dominant LMNA mutations and express approximately equal
amounts of mutant and wild-type lamins. Furthermore, expres-
sing the mutations in the Lmna+/2 MEF background and com-
paring them with Lmna+/+ and Lmna2/2 MEFs enabled us to
distinguish whether any observed effects of specific mutations
were dominant-negative or caused by a loss-of-function of the
mutant lamin A protein (i.e. haploinsufficiency). We tested a
total of 15 mutations, representing EDMD (8 mutations),
DCM (4 mutations) and FPLD (3 mutations) (summarized in
Table 1). For comparison, we evaluated Lmna+/2 MEFs
stably expressing either the empty vector (mock control) or
wild-type lamin A. As an additional control, we assessed the
effect of a lamin A mutant lacking the N-terminal 33 amino
acids (DNLA), which are critical for the assembly of higher
order lamin structures. When expressed in mammalian cells,
DNLA fails to assemble into the lamina and disrupts the existing
lamin network, thus acting in a dominant-negative manner (35).
We confirmed that the modified cells expressed the lamin
constructs at physiological levels by western analysis
(Fig. 1B and Supplementary Material, Fig. S2). Moreover,
Figure 1.Myopathic mutations in LMNA have variable effects on nuclear stiffness. (A) Normalized nuclear strain measurements of skin fibroblasts from healthy
controls (green) and human patients with LMNA mutations that cause EDMD (red) or FPLD (blue). Measurements were performed at passage numbers between
P8 and P15. In our experiments, we observed no correlation between passage number and nuclear deformability. ∗∗∗P , 0.001, versus healthy controls. (B)
Expression levels of nuclear envelope proteins in Lmna+/2 MEFs stably expressing the empty vector (mock), wild-type lamin A, head-truncated DNLA or
disease-specific lamin A mutations. Actin was used as loading control. (C) Normalized nuclear strain measurements of unmodified Lmna+/+, Lmna2/2 and
Lmna+/2 fibroblasts, as well as of Lmna+/2 fibroblasts expressing specific lamin A mutations, wild-type lamin A, head-truncated DNLA or the empty
vector (mock). Expression of wild-type lamin A rescued nuclear stiffness to levels comparable with Lmna+/+ cells; in contrast, DNLA resulted in stiffness com-
parable with Lmna2/2 fibroblasts. ∗∗P , 0.01 and ∗∗∗P, 0.001, compared with Lmna+/2 MEFs expressing wild-type lamin A.
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expression levels of lamin B1 and other nuclear envelope pro-
teins such as emerin and lamin B receptor were not notably
altered by ectopic expression of the lamin A variants
(Fig. 1B). However, we found a decrease in the expression
levels of lamin B2 for some of the mutants, most prominently
for R453W, R482Q and L530P. Nuclear strain experiments
confirmed that the nuclear stiffness of non- and mock-
modified Lmna+/2 MEFs has an intermediate value compared
with that of Lmna+/+ and Lmna2/2 cells (19), consistent with
the lower levels of lamins A/C in these cells. Ectopic expres-
sion of wild-type lamin A in Lmna+/2 MEFs completely
restored nuclear stiffness to levels of Lmna+/+ MEFs
(Fig.1C), whereas expression of the dominant negative
DNLA mutant caused an increase in nuclear deformability in
the modified Lmna+/2 MEFs, resulting in values comparable
to Lmna2/2 cells. In contrast, none of the disease-causing
lamin mutations resulted in dominant-negative effects on
nuclear deformability. Four of the tested lamin A mutants
associated with muscular disease, i.e. N195K (DCM),
E358K (EDMD), M371K (EDMD) and R386K (EDMD),
failed to restore nuclear stiffness and caused nuclear deforma-
tions similar to those observed in mock and non-modified
Lmna+/2 MEFs. These findings imply that these mutant
lamins result in a loss of structural function and fail to form
a lamina network that can withstand mechanical forces as
efficiently as a lamina formed from wild-type lamin. Although
these findings implicate increased nuclear deformability in the
pathogenesis of myopathic laminopathies, other DCM and
EDMD mutations partially or completely restored nuclear
stiffness (Fig. 1C), indicating that additional mechanisms
may contribute to the disease mechanism. Importantly, all
three tested FPLD mutations completely restored nuclear stiff-
ness as efficiently as wild-type lamin A, suggesting that the
FPLD mutations have no effect on the structural function of
lamin A.
Myopathic lamin A mutations that cause defects in nuclear
stability are more soluble
To investigate possible molecular mechanisms for the loss of
structural functions in some of the EDMD and DCM muta-
tions, we investigated the intranuclear localization of the
various mutants, as increased nucleoplasmic localization
could indicate impaired incorporation of mutant proteins into
the nuclear lamina. In wild-type cells and in Lmna+/2
MEFs expressing wild-type lamin A, lamins A/C were pre-
dominantly localized at the nuclear rim (Fig. 2A). In contrast,
cells expressing any of the mutations associated with the loss
of nuclear stability (i.e. N195K, E358K, M371K and R386K
and DNLA) had a prominent nucleoplasmic localization of
lamins A and C (Fig. 2A). Since lamin A/C-deficient cells
have an abnormal distribution of emerin (34), we also assessed
expression and localization of emerin in our panel of cells.
However, we did not observe any obvious defects in emerin
expression (Fig. 1B) or localization (Supplementary Material,
Fig. S3). Since the nucleoplasmic pool of lamin A was
increased in cells expressing the lamin A variants N195K,
E358K, M371K and R386K and the DNLA construct, we
next quantified the soluble fraction of lamin A in these cells
by a sequential protein extraction procedure using mild deter-
gents (36). Cells expressing DNLA and the N195K, E358K,
M371K and R386K mutants had substantially increased frac-
tions of soluble lamin A compared with wild-type expressing
cells (Fig. 2B and C), suggesting that these lamin A mutations
fail to correctly incorporate into the nuclear lamina and
thereby result in impaired nuclear stability.
Different amino acid substitutions in the same amino acid
positions can have distinct effects on lamin structural
function
All lamins share a conserved, tripartite organization compris-
ing a central coiled-coil rod domain, as well as non-helical
head and tail domains (37,38). The coiled-coil rod is the prin-
cipal subunit for all structural states, both for extended fila-
ments and for more complex arrays formed from filaments
as revealed early on by in vitro assembly studies (39) and re-
cently developed further in detail by cryoelectron tomography
(40). It is clear from these studies that these coiled coils inter-
act by multiple longitudinal and lateral interactions mediated
by the many ionic side chains that are found on the surface
of the coiled coil, to form higher order structures. Strikingly,
the four mutations that had the most severe effects on
Table 1. Human disease-associated LMNA mutations used in this study
Mutation Disease Reference
DK32 EDMD (68)
R60G DCM-CD, DCM-CD + FPLD,
DCM-CD + FPLD + CMT2
(62)
L85R DCM-CD (62)
N195K DCM-CD (62)
E203G DCM-CD (62)
E203K DCM-CD (77)
E358K EDMD (78)
M371K EDMD (78)
R386K EDMD (78)
R453W EDMD, EDMD + FPLD, LGMD1B (78)
R482Q FPLD (79)
R482W FPLD, FPLD + LGMD (80)
K486N FPLD (81)
W520S EDMD (78)
R527P EDMD, EDMD + FPLD, LGMD1B (82)
T528K EDMD, LGMD1B (78)
L530P EDMD (82)
DNLA Synthetic dominant-negative construct (35)
The tested mutations were R60G, L85R, N195K E203K and E203G, causing
DCM (62,77); DK32, E358K, M371K, R386K, R453W, W520S, R527P,
T528K and L530P, found in patients with EDMD (68,78,82); and R482Q,
R482W and K486N, identified in patients with FPLD (79–81). In addition, we
expressed the engineered dominant-negative construct DNLA, which disrupts
endogenous lamin organization (35). Note that, although most mutations affect
both lamin A and lamin C, we expressed only modified lamin A in MEF cells.
EDMD, Emery–Dreifuss muscular dystrophy; LGMD1B, limb–girdle
muscular dystrophy type 1B; DCM-CD, dilated cardiomyopathy with
conduction defect; CMT2, autosomal recessive Charcot–Marie–Tooth
disease; FPLD, familial partial lipodystrophy type Dunnigan (FPLD2). For
additional information on these mutations, see also http://www.umd.be/
LMNA/.
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nuclear structure were localized within, or in the case of
R386K just three amino acids after the predicted coiled-coil
rod domain of lamin A (41) (Supplementary Material,
Fig. S4A). Moreover, the mutated amino acids were located
in the outward-facing positions f or g of the heptad repeat of
the coiled-coil dimer (Supplementary Material, Fig. S4B)
and were substitutions to the positively charged lysine. On
the other hand, substitution of E203, another outward-facing
position in the central rod heptad repeat, to the neutral
glycine had no effect on the structural function of the
protein. Based on these findings, we hypothesized that muta-
tions to lysine in these outward-facing positions might inter-
fere with the higher order assembly of lamin dimers. We
therefore tested whether substitutions to small uncharged
amino acids (alanine, glycine) could restore normal nuclear
stiffness. In the case of E358, both alanine and glycine substi-
tutions rescued nuclear stiffness, supporting our hypothesis.
However, in the case of M371, only the glycine substitution
restored nuclear stiffness, whereas substitution to alanine
resulted in increased nuclear deformability; conversely, in
the case of R386, only alanine but not glycine rescued
nuclear stiffness (Supplementary Material, Fig. S4C). In add-
ition, we tested whether mutation of amino acid E203 to lysine
resulted in increased deformability, i.e. a loss of structural
function. Surprisingly, neither lysine nor alanine at position
E203 caused nuclei to become more deformable. These data
suggest that each individual amino acid position and each sub-
stitution can have different effects on structural functions of
lamin A and the corresponding nuclear stiffness, consistent
with the finding that different amino acid substitutions in the
same position can result in different laminopathies (13).
Lamin mutations that cause impaired nuclear stability
have disturbed filament and paracrystal assembly in vitro
Since our solubility studies suggested that lamin A mutants
that have impaired structural function fail to correctly incorp-
orate into the lamina network, we decided to directly assess
their assembly into higher order structures. Recombinant
human lamin A can be induced to assemble into either para-
crystalline structures or filaments in vitro, depending on
buffer conditions and dialysis procedure (42). We evaluated
wild-type lamin A and three lamin mutations that caused the
loss of structural function in our nuclear strain assay,
namely DK32, N195K and E358K mutants (Fig. 1A and C).
Although wild-type lamin A formed the expected large struc-
tures of laterally organized fibers (paracrystalline arrays), the
three lamin A mutants failed to assemble into well-organized
structures and instead formed small aggregates lacking the
typical 24.5 nm repeat pattern (Fig. 3, top row and Supplemen-
tary Material, Fig. S5). Similarly, only wild-type lamin A
assembled into regular extended filaments in vitro (Fig. 3,
bottom row and Supplementary Material, Fig. S5). These
results suggest that the loss of structural properties of lamins
through distinct mutations associated with more deformable
nuclei is caused by impaired assembly interactions of
the mutant proteins, consistent with recent reports on
Caenorhabditis elegans lamin carrying amino acid substitu-
tions that correspond to laminopathic mutations (43,44).
Nuclei of D. melanogaster larvae body wall muscle
expressing disease-causing Lamin C variants are more
deformable
To test whether lamin mutations associated with muscular dys-
trophy also cause defects in nuclear stability in muscle tissue,
we developed a novel experimental assay that enables us to
examine nuclear deformability in the intact body wall
muscle of D. melanogaster third instar larvae subjected to
mechanical strain (Fig. 4A and B). D. melanogaster possesses
genes encoding Lamin C and lamin Dm0, considered to share
properties with mammalian A- and B-types, respectively.
D. melanogaster can serve as a model to study human lamino-
pathies (45–47), and flies and larvae lacking Lamin C show
similar defects in nuclear structure as cells from Lmna2/2
mice and patients with EDMD (47). Muscle-specific expres-
sion of Drosophila Lamin C possessing mutations modeled
after those causing human muscle laminopathies leads to
larval locomotion defects, nuclear and cytoplasmic abnormal-
ities and, in some cases, lethality at the pupal stage (46). We
assessed nuclear deformability in the body wall muscles of
six different D. melanogaster strains, expressing wild-type
Lamin C, the headless variant of Lamin C lacking the first
42 amino acids (Lamin C DN) (47), and the Lamin C variants
N210K, R401K, K493W, W557S and L567P, corresponding
to the human point mutations N195K, R386K, R453W,
W520S and L530P, respectively, which cause DCM
(N195K) and EDMD (R386K, R453W, W520S and L530P)
in humans. The mutant lamins were expressed using the
Gal4/UAS system (48), with the C57 Gal4 driver stock provid-
ing the muscle specificity (49). Note that the wild-type and
mutant lamins were expressed in an otherwise wild-type
genetic background, allowing for tests of dominant-negative
function. Body wall muscle expressing the DN mutation had
misshapen nuclei (Fig. 4B), consistent with previous reports
(46). These nuclei also deformed significantly more under
applied strain, compared with muscle nuclei expressing wild-
type lamin and non-transgenic larvae (Fig. 4C). Similar to our
results in MEFs, where only the DNLA mutation caused
dominant-negative effects on nuclear stiffness, muscle-specific
expression of lamin point mutations resulted in substantially
milder disturbances in nuclear deformability. Although the
differences were not statistically significant compared with
the expression of wild-type Drosophila Lamin C, we observed
a clear trend toward softer nuclei of larvae muscle expressing
EDMD mutations (Fig. 4C). This reduced effect on nuclear
stiffness in Drosophila muscle cells, compared with MEF
cells, could be attributed to the fact that in the Drosophila
system mutations were expressed in a wild-type background
of Lamin C expression, whereas in MEF cells mutations
were expressed in a Lmna+/2 background. Importantly,
nuclear stiffness of epidermal cells, which did not express
the mutant lamins, was indistinguishable between all strains,
including larvae with muscle-specific expression of the DN
mutant (1.248+ 0.019 for unmodified larvae, 1.239+ 0.017
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Figure 2. Myopathic lamin A mutations that cause defects in nuclear stability have increased nucleoplasmic distribution and are more soluble. (A) Immuno-
fluorescence staining for lamin A/C in Lmna+/2 fibroblasts stably expressing the empty vector (mock), wild-type lamin A, head-truncated DNLA or disease-
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and 1.248+ 0.023 for wild-type and DN-expressing larvae, re-
spectively), confirming that the observed defects in the myo-
nuclei were a direct consequence of the muscle-specific
expression of Lamin C mutants.
Laminopathic lamin A mutations disrupt
nucleo-cytoskeletal coupling
Our findings that only a subset of the DCM- or EDMD-causing
mutations resulted in significantly impaired nuclear stability
suggests that additional mechanisms may contribute to the
muscular phenotype. One such mechanism could be that
lamin mutations disrupt the physical coupling between the
nucleus and cytoskeleton, which plays important roles in
muscle function. Lamins A/C interact with inner nuclear mem-
brane proteins containing a SUN (Sad1p and Unc-84 hom-
ology) domain such as Sun1 and Sun2 (50). Through the
SUN domain, these proteins associate across the perinuclear
space with the KASH (Klarsicht, Anc-1 and Syne homology)
domain of a protein family termed nesprins (51–53) located
on the outer nuclear membrane; nesprins in turn connect to
cytoskeletal components including actin, microtubules (via
dynein) and intermediate filaments (via plectin) (14,54).
Lamin mutations could interfere with this nucleo-cytoskeletal
connection, and defects in nucleo-cytoskeletal coupling and
anchoring have been reported in Lmna2/2 mice (16) and
MEFs (15,55). To directly test the effect of specific lamin
mutations on intracellular force transmission between the
nucleus and cytoskeleton, we applied a technique recently
developed in our laboratory (15), in which we locally apply
force to the cytoskeleton while measuring the induced
nuclear and cytoskeletal displacements across the cell
(Fig. 5A). We performed these measurements on Lmna+/2
MEFs stably expressing the empty vector (mock), wild-type
lamin A or five different laminopathic lamin A mutations:
E203G causing DCM; R453W and T528K causing EDMD;
and the FPLD mutations R482W and K486N. Importantly,
all of these mutations displayed normal nuclear deformability
in our nuclear strain assays (Fig. 1C). For comparison, we
included Lmna+/+ MEFs, which serve as control for normal
nucleo-cytoskeletal coupling, and Lmna+/2 MEFs stably
expressing a dominant-negative nesprin mutant consisting of
the KASH domain of human nesprin 1a (DN KASH) that is
sufficient to disrupt nucleo-cytoskeletal coupling by displacing
endogenous nesprins into the endoplasmic reticulum (15).
Lmna+/2 MEFs expressing either the empty vector (mock)
or DN KASH had significantly impaired force transmission
between the nucleus and cytoskeleton, as reflected by
smaller nuclear and cytoskeletal displacements in areas away
from the force application site (Fig. 5B) compared with
Lmna+/+ MEFs. This indicates that lamin A expression
levels from only one functional Lmna allele is not sufficient
to establish the LINC complexes necessary to provide as
strong a coupling between the nucleus and the cytoplasm as
in Lmna+/+ MEFs. Reintroduction of wild-type lamin A was
sufficient to completely restore intracellular force transmission
in Lmna+/2 cells to levels comparable with Lmna+/+ MEFs
(Fig. 5B). In contrast, all tested mutations, with the exception
Figure 3. Impaired in vitro assembly of myopathic lamin A mutations that alter nuclear mechanical properties. Recombinant human wild-type lamin A DC18
(i.e. mature lamin A) as well as the single-amino-acid deletion DK32 and the point mutations N195K and E358K were induced to assemble into paracrystalline
structures (upper panel) or filaments (lower panel) in vitro and imaged by transmission electron microscopy. In contrast to wild-type lamin A, the lamin A var-
iants DK32, N195K and E358K failed to assemble into regularly-organized structures and instead formed irregular aggregates. Scale bar: 0.2 mm.
specific lamin A mutations (upper panels) and overlaid with the ZsGreen signal and DAPI chromatin staining (lower panels). Cells expressing the DNLA,
N195K, E358K, M371K and R386K mutations have increased nucleoplasmic localization of lamin A/C. Scale bar: 20 mm. (B) Soluble lamin A protein fraction
(S) versus total lamin A and C levels in Lmna+/2 fibroblasts stably expressing the empty vector (mock), wild-type lamin A, head-truncated DNLA or disease-
specific lamin A mutations, as detected by western analysis. The soluble fraction contains lamin protein that is not incorporated into the nuclear lamina, and was
therefore extracted by treatment of cells with mild detergent. Note that only 1/30 of the total lamin A fraction, compared with the soluble fraction, was loaded on
the gel. Similar protein levels were loaded, as reflected by actin staining. Since different amount of cells were loaded onto gels for each cell line, a direct com-
parison of amounts of soluble or total Lamin A fraction between cell lines is not possible, and it is the ratio between soluble to total protein that is used for the
interpretation of the results. Extraction was performed three independent times; one representative panel is shown. (C) Quantification of the soluble lamin A
fraction of the cells analyzed in (B), indicating that DNLA and the disease-specific lamin variants N195K, E358K, M371K and R386K are more soluble
than wild-type lamin A and other lamin variants.
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of the E203G mutant, failed to rescue intracellular force trans-
mission (Fig. 5B), indicating that these mutations interfere
with nucleo-cytoskeletal coupling despite having apparently
normal incorporation into the nuclear lamina and maintaining
normal nuclear stiffness. Surprisingly, these defects were also
visible in the two FPLD mutations.
Figure 5. Laminopathic lamin A mutations disrupt force transmission between the nucleus and cytoskeleton. (A) Schematic overview of the microneedle ma-
nipulation experiments to assess intracellular force transmission between the nucleus and cytoskeleton. A fine microneedle is inserted into the cytoplasm near the
nucleus and moved toward the periphery (left panel). Displacement maps of the cytoskeleton (middle panel) and the nucleus (right panel) are plotted by tracking
intracellular fluorescent markers; measurements of the average displacements within four defined areas inside the cytoplasm and nucleus (indicated by dotted
boxes in the left panel) are used to evaluate the intracellular force transmission between the nucleus and cytoskeleton. Scale bar: 20 mm. (B) Average displace-
ments at the indicated regions in Lmna+/+ MEFs, and in Lmna+/2 fibroblasts stably expressing the empty vector (mock), wild-type lamin A, head-truncated
DNLA or disease-specific lamin A mutations. The displacements in the first cytoskeletal region were comparable in all cells, illustrating similar strain application
with the microneedle. Lmna+/2 cells expressing mutant lamins (except for the E203G mutations) and the empty vector had significantly smaller nuclear and
cytoskeletal displacements in the three cellular regions observed away from the site of strain application compared with Lmna+/2 cells expressing wild-type
lamin A or non-modified Lmna+/+ cells, indicating reduced intracellular force transmission between the nucleus and cytoskeleton in the mutant cells.
∗P, 0.05; ∗∗P, 0.01; ∗∗∗P , 0.001 versus Lmna+/2 MEFs expressing wild-type lamin A.
Figure 4. Decreased nuclear stiffness in body wall muscle of D. melanogaster larvae expressing Lamin C variants causing EDMD. (A) Overview of the experi-
mental approach to observe nuclear deformations in D. melanogaster larval filet subjected to strain application. Upper panel: the larval filet, consisting of the
body wall muscle, is glued to a transparent silicone membrane (left panel); individual muscle fibers are easily detectable (middle and right panel, with distinct
muscle fibers highlighted in the right panel). Lower panel: although biaxial strain is applied to the Drosophila larval filet, the tissue strain in the muscle fibers is
almost completely uniaxial in the direction of the muscle fiber. (B) Change in nuclear shape in pre-stretched and fully stretched muscle strands of larvae expres-
sing wild-type Lamin C (the A-type lamin of D. melanogaster), head-truncated DN Lamin C or the W557S Lamin C mutation, which corresponds to the human
LMNA W520S mutation. Muscle cells expressing the DN lamin mutation deformed significantly more under applied strain. Images in the lower panel represent
nuclei under strain, overlaid with the nuclear contour from the pre-stretch state in red. (C) Normalized nuclear stiffness of D. melanogaster larvae expressing
wild-type D. melanogaster Lamin C, head-truncated Lamin C DN or Lamin C mutations (labeled in black) that correspond to human EDMD-causing LMNA
mutations (labeled in red). ∗∗∗P, 0.001, compared with muscle nuclei expressing wild-type Lamin C.
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DISCUSSION
The finding that different mutations in the LMNA gene cause a
variety of human diseases and that many of these mutations
result in tissue-specific defects has continued to puzzle
researchers for years. Gross alterations in nuclear morphology
are often noted as a hallmark of laminopathies (24–29,31),
and biopsies from muscular dystrophy and DCM patients have
revealed defects in nuclear envelope continuity, loss of com-
partmentalization and even the presence of mitochondria
within the nuclear interior (25,30,56), suggesting physical
damage to mechanically fragile nuclei. Nonetheless, it has
remained unclear to what extent mechanical defects, i.e.
impaired nuclear structure and stability or disruption of nucleo-
cytoskeletal connections, contribute to the development of mus-
cular phenotypes observed in many laminopathies.
We performed a comparative study on the effect of a panel
of lamin mutations, representing EDMD, DCM and FPLD, on
nuclear mechanical properties. We used human patient fibro-
blasts as well as Lmna+/2 MEFs modified to express different
disease-causing lamin A mutations. The latter cell line was
previously reported to still express a truncated fragment of
lamin A (57). In our studies, we found Lmna+/+, Lmna+/2
and Lmna2/2 MEFs to be a valid system to test the effect
of laminopathic mutations on nuclear stability: we found
that nuclear stiffness shows a dose-dependent increase with
the amount of wild-type lamin A, and nuclear deformability
increases with loss of its expression (Fig. 1C). Moreover, the
reintroduction of wild-lamin A into Lmna+/2 MEFs complete-
ly restored nuclear stiffness to values comparable with
Lmna+/+ MEFs. Therefore, the truncated lamin A fragment
present in the Lmna+/2 and Lmna2/2 MEFs had no effect
on nuclear deformability.
In our studies on both patient cells and modified Lmna+/2
MEFs, we found that all lamin mutants responsible for FPLD
had normal nuclear stiffness. In contrast, several mutations
associated with EDMD and DCM resulted in a loss of nuclear
stability, as evidenced by increased deformation of the nuclei
and enhanced sensitivity to mechanical strain. The findings
are consistent with previous reports that FPLD mutations,
which are often clustered around a small surface region of the
lamin Ig-fold, do not affect lamin diffusional mobility
(58,59). Of note, we found the most severe defects in EDMD
and DCM mutations affecting the N-terminal domain of
A-type lamins and specific amino acid substitutions in outward-
facing positions of the coiled coil of the central rod, implying
that defects in the higher order assembly of lamins are respon-
sible for the loss of structural function. We speculate that dis-
tinct myopathic mutations might have effects on the lamina
network and nuclear integrity due to impaired assembly into
the lamina network. Therefore, a large fraction of these
mutant proteins remains nucleoplasmic and more soluble, so
that the lamina cannot adequately support nuclear stability.
Other mutations might have more subtle effects on assembly
or produce minor irregularities in the lamina lattice, which are
not easily detectable in our nuclear strain assays. Unlike the
nuclear strain experiments, our in vitro assembly studies,
which revealed severed defects in filament and paracrystal as-
sembly of lamin mutants causing EDMD, were performed in
the absence of wild-type lamin A. Although we cannot
exclude the possibility that the presence of wild-type lamin A
could assist in the formation of more regular-appearing struc-
tures comprised of mutant and wild-type lamins (which would
likely still be mechanically weaker), previous co-assembly
studies with wild-type and mutant desmin found that the
mutant protein segregates in vitro and in vivo (60,61), which
would also provide an explanation for the increased solubility
of the mutant lamins in our studies (Fig. 2).
We found that different amino acid substitutions at the same
amino acid position within the central rod domain can have
very distinct effects on nuclear deformability. This observa-
tion may at least in part explain why some amino acid substi-
tutions at specific positions are more prevalent among patients
with LMNA mutations than others. For example, for position
E203, both E203K and E203G substitutions have been identi-
fied in patients with DCM, whereas substitution to E203A,
which had normal structural function in our nuclear strain
assay, has never been reported in patients. Similarly, for pos-
ition E358, the E358K mutation is the only reported amino
acid change reported in severe muscular dystrophy, and pos-
ition R386 has been reported mutated to lysine (K), threonine
(T), or methionine (M), but not to glycine (G) or alanine (A).
Although this preference for specific amino acid substitutions
may simply represent underreporting of disease mutations or
the rarity of LMNA mutations, it is intriguing to consider the
possibility that the fact that some amino acid substitutions
have not been reported in patients may indicate that these
changes either have no profound effects or are so deleterious
that they are lethal during development.
Using muscle-specific expression of myopathic lamin
mutants in D. melanogaster, we provided the first direct evi-
dence that lamin mutations impair nuclear stability in
muscle fibers subjected to mechanical strain. Interestingly,
the N210K mutation, which corresponds to the human
N195K mutation that causes DCM, had no effect on nuclear
stability in the Drosophila body wall muscle, which may indi-
cate that lamin mutations can differentially affect nuclear
structure and mechanics in skeletal and cardiac muscle. This
idea is further supported by the fact that patients carrying
the LMNA N195K mutation show no clinical symptoms
typical for muscular dystrophy, and skeletal muscle biopsies
exhibit no pathology (62).
Although our findings strongly support a role for impaired
nuclear mechanics in the development of muscular phenotypes
in laminopathy patients, it is important to note that only four of
the 12 EDMD and DCM mutations caused severe defects in
nuclear stability, whereas other mutations displayed normal
nuclear stiffness in our assays and yet cause EDMD or DCM in
humans. For cases in which no obvious defect in nuclear
stability was observed, we cannot exclude the possibility that ab-
normalities are masked by impaired nucleo-cytoskeletal coup-
ling. However, considering the strong correlation between
nuclear deformation (Fig. 1C) and solubility of mutant lamins
(Fig. 2C), it seems likely that our measurements reflect specific
differences in structural function of different lamin mutations.
This idea is supported by prior observations using C2C12 myo-
blasts that demonstrated diffuse, nucleoplasmic localization in
transfected cells for the same four mutations we found to be de-
fective in providing nuclear stability (63). For cases where we
did not observe negative effects on nuclear stiffness, we favor
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the explanation that additional factors must contribute to the de-
velopment of muscular disease, specifically a disruption of
nucleo-cytoskeletal connections. In support of this hypothesis,
we observed defects in intracellular force transmission
(Fig. 5B). Our findings are consistent with a recent report in
which laminopathic mutations associated with DCM and
EDMD caused impaired nuclear movement in MEFs, which
was attributed to defects in the attachment of cytoskeletal actin
cables to the nuclear lamina via nesprin-2 giant/Sun2 complexes
termed transmembrane actin-associated nuclear lines (55).
One potential limitation of the current studies is that we
investigated mutations in lamin A only, whereas most
human mutations affect both lamins A and C. However, we
found that the expression of lamin A was sufficient to com-
pletely restore nuclear stiffness in Lmna+/2 MEFs, suggesting
some redundancy between these two isoforms, which is con-
sistent with the lack of phenotype in mice lacking either
lamin A or C (64–66). In addition, we obtained similar
results in Drosophila muscle fibers which express only a
single A-type lamin.
Taken together, our findings demonstrate the complexity of
lamin mutations and their effect on nuclear structure and sta-
bility in muscle diseases. Many, but not all, mutations asso-
ciated with EDMD and DCM are characterized by defects in
structural function, resulting in more deformable and more
fragile nuclei, which could render cells more sensitive to
mechanical stress. In addition, all tested EDMD mutations dis-
rupted nucleo-cytoskeletal coupling, which could further
impair muscle function, for example, by failure of myonuclei
to anchor at neuromuscular junctions (16). In addition to these
mechanical aspects, it is likely that lamin mutations can inter-
fere with a broad range of other cellular processes requiring
lamins, including replication, gene expression, DNA repair,
proliferation and stem-cell differentiation (10,21). In this scen-
ario, different lamin mutations may specifically impact one or
more of these functions, thus explaining the broad spectrum of
human diseases caused by the diverse LMNA mutations.
MATERIALS AND METHODS
Cell lines
Lmna+/+, Lmna+/2 and Lmna2/2 MEFs were cultured in
D10 medium (DMEM supplemented with 10% fetal bovine
serum, 4 mM L-glutamine, 50 U/ml penicillin and 50 mg/ml
streptomycin). 293GPG cells (67) were cultured in D10 sup-
plemented with 1 mg/ml tetracycline, 2 mg/ml puromycin
and 300 mg/ml G418. Human patient fibroblasts (68) were
kindly provided by Howard Worman (Columbia University,
New York, NY, USA) and maintained in D10 containing
5 mg/ml PlasmocinTM (InvivoGen) for prophylactic treatment
against mycoplasma contamination.
Plasmids
cDNAs of wild-type and point-mutated human prelamin A, as
well as the DNLA lamin variant lacking the first 33 amino
acids, were kindly provided by Howard Worman [Columbia
University, New York, NY, USA (63)]. The point-mutated
cDNAs used in this study cause amino acid substitutions as
shown in Table 1. Lamin variants were either amplified by
PCR and ligated into pRetroX-IRES-ZsGreen1 using NotI
and BamHI restriction sites, or subcloned from a shuttle
vector as described previously (69). Mutagenesis of the
codons of amino acids E203, E358, M371 and R386 to
either glycine or alanine was performed by amplifying
human prelamin A in two fragments and inducing codon
changes over the respective primers. After PCR, the two frag-
ments were ligated together via an introduced restriction site
that does not change the primary sequence of the prelamin
A protein (introducing BspDI at amino acid positions 195–
196: 583–588acaggcatcgat results in N195N, G196G;
introducing EcoRV at amino acid positions 364 and 365:
1090–1095gacatcgatatc results in D364D, I365I; or intro-
ducing XhoI at amino acid positions 380 and 381: 1138–
1142ttggagctcgag results in L380L, E381E). As control,
primers with the same introduced restriction sites but
without amino acid change in positions E203, E358, M371
and R386 were used to amplify the two prelamin A fragments
that were ligated together. Ligated full-length prelamin A var-
iants were ligated into pRetroX-IRES-ZsGreen1 using NotI
and BamHI restriction sites. The dominant-negative nesprin
KASH (DN KASH) plasmid was described previously (15).
Constructs encoding the mutant forms of Drosophila Lamin
C were generated using the QuikChange II Site-Directed Mu-
tagenesis Kit. The primers contain nucleotide substitutions
that result in single-amino-acid substitutions within Lamin
C. The mutated Lamin C sequences were cloned into the
P-element transformation vector pUAST (70) and used to gen-
erate transgenic stocks (45). For all mutagenesis procedures,
introduced mutations were confirmed by sequencing.
Retroviral infection and cell sorting
Lmna+/2 MEFs were modified by retroviral infection.
293GPG cells were transfected with pRetroX-IRES-ZsGreen1
vectors containing lamin A variants, using LipofectamineTM
2000 (Invitrogen). Starting 6 h after transfection, cells were
maintained in D10 without tetracycline, puromycin and
G418. For 6 subsequent days, cell medium was collected
and replaced. This medium containing assembled virus was
filtered through 0.45 mm pores, supplemented with 8 mg/ml
Polybrene and added to Lmna+/2 MEFs for 24 h. At 5–10
days after retroviral infection, positive cells were sorted for
the bicistronically expressed ZsGreen, which allowed us to
finely control expression levels of the ectopically expressed
lamins translated from the same bicistronic mRNA. Cell
sorting was performed on a BD FACSARIA Special Order
11 color sorter, using a 488 nm laser to excite ZsGreen1 and
with a sort pressure of 70 psi.
Protein extraction
Preparation of total cell extracts containing 3 × 105 cells per
microliters was performed as previously described by resus-
pending pelleted cells in Laemmli sample buffer (LSB, 10%
glycerol, 3% SDS, 62.5 mM Tris–HCl, 50 mM DTT and
0.05% bromphenol blue) and subsequent boiling for 5 min
(71). Extraction of the soluble lamin A/C fraction of modified
and unmodified Lmna+/2 MEFs was performed following a
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modified protocol for differential protein extraction (36). Con-
fluent cells were washed with phosphate-buffered saline
(PBS), trypsinized and resuspended in 1.2 ml of growth
medium. An amount of 33 ml of the cell suspension was im-
mediately boiled with 267 ml of LSB (‘total cell fraction’).
Another 1 ml of aliquot (‘soluble lamin fraction’) of the cell
suspension was transferred into a new tube; cells were
briefly spun down and resuspended in 200 ml of lysis buffer
containing 0.5× PBS, 50 mM MOPS (pH 7.0), 10 mM
MgCl2, 1 mM EGTA, 1% NP40, protease inhibitor
(SIGMAFASTTM Protease Inhibitor, Sigma-Aldrich) and
0.75% saturated PMSF in ethanol. Extraction with 1% NP40
detergent was previously shown to release the soluble lamin
A/C fraction but not lamina-associated A-type lamins (36).
Extraction was performed at room temperature for 5 min;
cell remnants were spun down, and 150 ml of the supernatant
were boiled with 75 ml of 3× LSB. Extraction was performed
three independent times. Notably, owing to slight changes in
experimental conditions for each isolation, e.g. cell density,
buffer composition, vortexing or extraction timing, the abso-
lute results of the soluble lamin fractions varied between indi-
vidual experiments, even though the relative difference
between cell lines within each experiment were very similar.
Immunofluorescence analysis
Immunofluorescence analysis was performed as previously
described (71). In brief, cells were plated on sterile coverslips
and grown overnight, briefly washed with PBS, fixed in 4% for-
maldehyde (pH 7.4) and permeabilized with 0.5% Triton X-100
in PBS. Fixed cells were incubated either withmouse anti-lamin
A/C antibody [LaZ (72)] or with guinea pig anti-emerin anti-
body [Em-N-term (73)], diluted 1:2 and 1:300, respectively,
in PBS containing 10% normal donkey serum (Jackson Immu-
noResearch). Cells were washed and incubated with secondary
antibodies: Cy3-coupled donkey anti-mouse or donkey anti-
guinea pig IgG, diluted 1:500 in PBS containing 10% normal
donkey serum. Cells were then incubated in 2 mg/ml Hoechst
33342 and embedded in Eukitt quick-hardening mounting
medium (Fluka). Confocal laser scanning microscopy was per-
formed on a TCS-SP II microscope (Leica Microsystems).
Images were acquired with a 63.0× oil-immersion objective
(NA 1.40) with a 1 airy unit pinhole.
Western analysis
Western analysis of modified and unmodified Lmna+/2 MEFs
was performed as previously described (71). Polyvinylidene
difluoride membranes were incubated with the following anti-
bodies diluted in PBS containing 0.5% Tween-20 and 5% milk
powder: mouse anti-lamin A/C antibody (LaZ) at 1:5 dilution,
goat anti-lamin A/C antibody (N-18, Santa Cruz #sc-6215) at
1:500 dilution, goat anti-lamin B1 antibody (M-20, Santa Cruz
#sc-6217) at 1:500 dilution, mouse anti-lamin B2 antibody
(X223, Progen #65147C) at 1:5 dilution, guinea pig anti-
emerin antibody (Em-N-term) at 1:2000 dilution and rabbit
anti-actin antibody (Sigma-Aldrich, #20–33) at 1:5000 dilu-
tion. Membranes were washed in PBS containing 0.5%
Tween-20 and incubated with secondary antibodies:
peroxidase-coupled donkey anti-guinea pig, donkey anti-
rabbit, donkey anti-goat or donkey anti-mouse IgG (Jackson
ImmunoReseach) diluted 1:5000 in PBS containing 0.5%
Tween-20 and 5% milk powder. Enhanced luminescence reac-
tion was performed and membranes were exposed to X-ray
films.
Drosophila stocks
Generation of transgenic stocks was performed as previously
described (45). Stocks expressing wild-type and mutant
lamins under the control of a UAS element were crossed to
the C57 Gal4 driver stock (49) and the resulting larval
progeny were analyzed for muscle defects (45). The lamin
stocks encode wild-type Lamin C, headless Lamin C
(lacking the first 42 amino acids, Lamin C DN) or the muta-
tions N210K, R401K, K493W, W557S and L567P (corre-
sponding to human mutations N195K, R386K, R453W,
W520S and L530P, respectively) (46,47,74). Drosophila
stocks were maintained on standard corn meal media at
room temperature; the Gal4/UAS crosses were performed at
258C.
Nuclear strain analysis and microneedle manipulation
assay of cultured cells
Nuclear strain analysis and microneedle manipulation of
patient fibroblasts and Lmna+/2 MEFs, as well as data ana-
lysis, were performed as described previously (32,75).
Nuclear strain analysis in muscle tissue
For nuclear strain analysis of D. melanogaster muscle tissue,
third instar larvae were placed in a drop of cold low-potassium
buffer containing 108 mM NaCl, 5 mM KCl, 2 mM CaCl2, 8 mM
MgCl2, 1 mM NaH2PO4, 4 mM NaHCO3, 10 mM sucrose, 5 mM
trehalose, 5 mM HEPES and 100 mg/ml Hoechst 33342 nuclear
stain on a glass slide. Subsequently, the head and tail were
removed and the body wall muscle was opened with a horizon-
tal incision down the length of the longitudinal axis to remove
the organs. The body wall muscle filet was then transferred
onto an elastic silicone membrane clamped into the strain
dish and covered with 15 ml of high-potassium buffer contain-
ing 108 mM NaCl, 35 mM KCl, 1 mM EDTA, 8 mM MgCl2,
1 mM NaH2PO4, 4 mM NaHCO3, 10 mM sucrose, 5 mM trehal-
ose, 5 mM HEPES and 10 mg/ml Hoechst 33342. To securely
attach the muscle filet in the open position to the center of
the silicone membrane, a small amount of histoacryl blue ad-
hesive (Tissue Seal, LLC) was applied to the four corners and
to two to four additional points along the periphery of the
muscle filet and then affixed to the silicone membrane. The
muscle filets were then subjected to biaxial strain application
as described previously for adherent cells (32,75), with
minor modifications. To facilitate imaging of muscle fibers,
the muscle filet was pre-stretched by applying low-level
biaxial strain to the silicon membrane, resulting in taut but
only lightly strained muscle fibers. Fluorescence images of
1–3 muscle fibers, containing up to 15 myonuclei, were
acquired at this position. Subsequently, the silicone membrane
was further stretched, resulting in larger tissue strain and
induced nuclear deformations. Importantly, although the
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applied membrane strain is biaxial, due to the muscle physi-
ology and attachment, the tissue strain in the muscle fibers
is almost completely uniaxial in the direction of the muscle
fiber. The same myonuclei were then imaged in this strained
condition. To calculate tissue strain, changes in the inter-
nuclear distance within a single muscle strand were calculated
using a custom-written MATLAB program. Nuclear deforma-
tions were then quantified as previously described (32,75).
In vitro lamin assembly
Recombinant human lamin A DC18 (‘mature’ lamin A) as
well as the single-amino-acid deletion DK32 and the point
mutations N195K and E358K were expressed using the
pET24 system. A clone coding for lamin A DK32 was gener-
ously provided by Gisele Bonne (Inserm U582 – Institut de
Myologie, Paris, France) and subcloned into pET24a. Induc-
tion with 1 mM IPTG was done for 3 h at 378C (42). Inclusion
bodies were isolated as described previously (76). For in vitro
paracrystal assembly, lamin protein stored in 8 M urea at a con-
centration of 0.5 mg/ml was dialyzed into 10 mM Tris–HCl
(pH 7.4), 300 mM NaCl, 2 mM EDTA and 1 mM DTT over-
night at 48C to obtain soluble lamin complexes. Lamins
were briefly centrifuged in a benchtop centrifuge at full
speed for 15 min to remove all protein at higher assembly
states. Lamin proteins were diluted to 0.1 mg/ml and further
dialyzed in the same buffer, but with stepwise reduction of
salt concentration from 300 to 50 mM NaCl. Each dialysis
step was performed for 20 min at 378C. For in vitro filament
assembly, lamin protein in 8 M urea at a concentration of
0.2 mg/ml was dialyzed into 25 mM Tris (pH 8), 250 mM
NaCl and 1 mM DTT for 1 h at 378C to obtain lamin dimers,
then dialyzed into 25 mM MES, pH 6.5, 250 mM NaCl and
1 mM DTT for 50 min at 378C. Assembled filaments, fixed
with 0.1% glutaraldehyde, and paracrystals were then
applied to glow-discharged, carbon-coated copper electron mi-
croscopy grids and analyzed in a Philips 410 transmission
electron microscope (FEI). Images were taken with a CCD
camera (Bioscan 792, Gatan).
Statistical data analysis
All measurements were performed at least three independent
times. All data are expressed as mean+ standard error of
the mean. Statistical analyses were performed with PRISM
3.0 (GraphPad Software, Inc.). Data were analyzed by a two-
tailed Student t-test (for comparison between two groups) or
one-way ANOVA with post-test for comparison of several
groups. A two-tailed P-value of ≤0.05 was considered signifi-
cant, with the symbols ‘∗’ for P ≤ 0.05, ‘∗∗’ for P ≤ 0.01 and
‘∗∗∗’ for P ≤ 0.001.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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